RaySearch Laboratories AB (FRA:27R)
€ 20.86 +0.48 (+2.36%) Market Cap: 714.63 Mil Enterprise Value: 709.05 Mil PE Ratio: 35.78 PB Ratio: 7.69 GF Score: 86/100

Q3 2024 RaySearch Laboratories AB (publ) Earnings Call Transcript

Nov 08, 2024 / 09:00AM GMT
Release Date Price: €14.1 (+4.14%)

Key Points

Positve
  • RaySearch Laboratories AB (RSLBF) reported its highest ever third-quarter sales, reaching SEK293 million, a 19% increase compared to the same period in 2023.
  • The company achieved an operating profit of SEK62 million, with an operating margin of 21%, demonstrating strong financial performance.
  • RaySearch Laboratories AB (RSLBF) has a robust financial position with cash and cash equivalents of SEK425 million and no loans.
  • The company has successfully expanded its market potential for RayCare by integrating with approximately 4,000 Varian TrueBeam machines worldwide.
  • RaySearch Laboratories AB (RSLBF) has seen a steady growth in net sales and operating results over a 12-month perspective, with net sales growing from SEK768 million to SEK1.169 billion by the end of September 2024.
Negative
  • The order intake for support decreased by 9% from SEK102 million to SEK93 million compared to the same period last year.
  • Cash flow from operations decreased to SEK60 million in the quarter compared to last year's SEK124 million, due to changes in operating liabilities.
  • Operating expenses increased by 5% from SEK194 million to SEK203 million compared to the same period last year.
  • Orders have been tracking slightly below sales in recent quarters, although the company is not concerned about this trend.
  • The cash flow for the period amounted to SEK1.7 million, a significant decrease from SEK64 million in the same period last year, attributed to changes in operating liabilities.
Eva Nelson;publ;Investor Relations
RaySearch Laboratories AB

()-

Hello, and welcome to the presentation of the RaySearch interim report on the third quarter of 2024. My name is Eva Gruber Nelson, and I will be the moderator here today. And joining us in today's call is, as always, Johan Lof, RaySearch Founder and CEO; and also Annika Blondeau Henriksson, the interim CFO.

Next slide, please. Johan and Annika will give you a short summary of the quarter first, including the financials. And after that, we open up for questions. And you can ask your question either orally or in writing. And I also want to remind you that this session is recorded, and you can find the same link as it used for this Teams meeting and also RaySearch website.

So with that, I hand over to you, Johan. Please go ahead.

Johan LÃ;f;publ;Chief Executive Officer
RaySearch Laboratories AB;Founder, Director

¶ - ()- -

Thank you, Eva. I would also like to welcome all of you to today's webcast.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot